title: Etravirine-based antiretroviral therapy in HIV/hepatitis C virus coinfected advanced fibrosis patients receiving triple therapy against hepatitis C virus with telaprevir.
authors.affiliation: aHospital Universitario La Paz, Madrid bHospital Ramón y Cajal, Madrid cComplexo Hospitalario Universitario de A Coruña, Madrid dHospital de Móstoles, Madrid eFacultad de ciencias Biomédicas, Especialidades Médicas, Psicología y Pedagogía Aplicadas, Universidad Europea, Madrid fHospital Universitario Príncipe de Asturias, Madrid gHospital Universitario La Princesa, Madrid hHospital Universitario Guadalajara, Madrid iHospital Universitario Gregorio Marañón, Madrid, Spain.
authors.forename: Maria Luisa Montes
authors.initials: ML
authors.lastname: Ramirez
authors.forename: Francisco X Zamora
authors.initials: FX
authors.lastname: Vargas
authors.forename: Juan
authors.initials: J
authors.lastname: González-Garcia
authors.forename: Carmen
authors.initials: C
authors.lastname: Quereda
authors.forename: Maria Jesús
authors.initials: MJ
authors.lastname: Pérez-Elías
authors.forename: Alvaro Mena
authors.initials: AM
authors.lastname: de Cea
authors.forename: Carlos
authors.initials: C
authors.lastname: Barros
authors.forename: Emilia
authors.initials: E
authors.lastname: Condés
authors.forename: Jose Sanz
authors.initials: JS
authors.lastname: Moreno
authors.forename: Ignacio
authors.initials: I
authors.lastname: Santos
authors.forename: Miguel
authors.initials: M
authors.lastname: Torralba
authors.forename: Teresa
authors.initials: T
authors.lastname: Aldamiz-Echevarria
authors.forename: Ana
authors.initials: A
authors.lastname: Moreno
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015331:Cohort Studies; D060085:Coinfection / Q000188:drug therapy*; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009570:Nitriles; D009842:Oligopeptides / Q000009:adverse effects / Q000627:therapeutic use*; D011724:Pyridazines / Q000009:adverse effects / Q000627:therapeutic use*; D011743:Pyrimidines; D012189:Retrospective Studies; D013030:Spain; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D009570:Nitriles; D009842:Oligopeptides; D011724:Pyridazines; D011743:Pyrimidines; C451734:etravirine; C486464:telaprevir